Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

BACKGROUND: Oxaliplatin is a chemotherapy agent active against digestive tumors. Peripheral neuropathy is one of the most important dose-limiting toxicity of this drug. It occurs in around 60–80% of the patients, and 15% of them develop severe neuropathy. The pathophysiology of oxaliplatin neurotoxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sereno, María, Gutiérrez-Gutiérrez, Gerardo, Rubio, Juan Moreno, Apellániz-Ruiz, María, Sánchez-Barroso, Lara, Casado, Enrique, Falagan, Sandra, López-Gómez, Miriam, Merino, María, Gómez-Raposo, César, Rodriguez-Salas, Nuria, Tébar, Francisco Zambrana, Rodríguez-Antona, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248487/
https://www.ncbi.nlm.nih.gov/pubmed/28103821
http://dx.doi.org/10.1186/s12885-016-3031-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248487/
https://www.ncbi.nlm.nih.gov/pubmed/28103821
http://dx.doi.org/10.1186/s12885-016-3031-5

Ejemplares similares